Recherche
-
Spontaneous reporting of adverse-drug reactions as an outlet for patient dismay? The case of Levothyrox(R) change of excipients
(Fundamental and Clinical Pharmacology, 2022-01-06)Article de revue -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, pp. 1981-1990, 2022-10-26)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue -
Chronic polypharmacy at all age: a population-based drug utilization study
(Fundamental and Clinical Pharmacology. vol. 36, n° 2, pp. 405-413, 2022-04)Article de revue -
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use
(Frontiers in Psychiatry. vol. 13, 2022-06-30)Article de revueLibre accès -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
(Therapies, 2022-12-09)Article de revue -
The risk of dementia in patients using psychotropic drugs: Antidepressants, mood stabilizers or antipsychotics
(Acta Psychiatrica Scandinavica. vol. 145, n° 1, pp. 56-66, 2022-01)Article de revue -
Antiherpetic drugs: a potential way to prevent Alzheimer's disease?
(Alzheimer's Research and Therapy. vol. 14, n° 1, pp. 3, 2022-01-07)Article de revueLibre accès -
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
(BMJ. vol. 376, 2022-03-23)Article de revueLibre accès